NSE:BIOFILCHEM Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	291.81	334.02	400.35	300.35	223.82	357.5
Other Revenue	30.85	1.8	3.73	-	-	0.59
Revenue	322.66	335.82	404.09	300.35	223.82	358.1
Revenue Growth (YoY)	-20.55%	-16.89%	34.54%	34.19%	-37.50%	20.30%
Cost of Revenue	271.58	310.16	376.61	274.72	195.16	324.83
Gross Profit	51.08	25.67	27.48	25.63	28.66	33.27
Selling, General & Admin	9.58	7.97	6.82	6.34	7.94	7.59
Other Operating Expenses	6.62	6.62	7.66	6.66	6.1	1.94
Operating Expenses	19.01	18.38	18.47	17.29	18.32	13.64
Operating Income	32.08	7.29	9	8.34	10.34	19.63
Interest Expense	-0.17	-0.36	-0.4	-0.42	-0.39	-0.64
Interest & Investment Income	0.44	0.44	0.07	0.02	0.21	0.21
Other Non Operating Income (Expenses)	-0.01	-0.01	-0.02	-0.01	-0.02	-0.04
EBT Excluding Unusual Items	32.34	7.36	8.65	7.93	10.15	19.16
Gain (Loss) on Sale of Assets	-	-	-	-	-	0.03
Pretax Income	32.34	7.36	8.65	7.93	10.15	19.19
Income Tax Expense	4.61	1.78	1.56	2.33	3.17	6.78
Net Income	27.73	5.58	7.09	5.6	6.98	12.41
Net Income to Common	27.73	5.58	7.09	5.6	6.98	12.41
Net Income Growth	357.04%	-21.36%	26.55%	-19.76%	-43.74%	2.83%
Shares Outstanding (Basic)	16	16	16	16	16	16
Shares Outstanding (Diluted)	16	16	16	16	16	16
Shares Change (YoY)	0.84%	-	-	-	-	-0.00%
EPS (Basic)	1.70	0.34	0.44	0.34	0.43	0.76
EPS (Diluted)	1.70	0.34	0.44	0.34	0.43	0.76
EPS Growth	352.51%	-21.98%	28.17%	-20.77%	-43.74%	3.08%
Free Cash Flow	-	-20.24	23.71	-1.22	-2.9	5.44
Free Cash Flow Per Share	-	-1.24	1.46	-0.07	-0.18	0.33
Gross Margin	15.83%	7.64%	6.80%	8.53%	12.80%	9.29%
Operating Margin	9.94%	2.17%	2.23%	2.78%	4.62%	5.48%
Profit Margin	8.60%	1.66%	1.75%	1.87%	3.12%	3.47%
Free Cash Flow Margin	-	-6.03%	5.87%	-0.41%	-1.29%	1.52%
EBITDA	35.72	11.08	13	12.63	14.62	23.75
EBITDA Margin	11.07%	3.30%	3.22%	4.21%	6.53%	6.63%
D&A For EBITDA	3.65	3.8	3.99	4.29	4.28	4.12
EBIT	32.08	7.29	9	8.34	10.34	19.63
EBIT Margin	9.94%	2.17%	2.23%	2.78%	4.62%	5.48%
Effective Tax Rate	14.26%	24.23%	18.04%	29.33%	31.19%	35.31%
Revenue as Reported	323.91	337.07	405.25	301.32	225.33	365.5
Advertising Expenses	-	0.12	0.12	0.1	0.07	0.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.